| pubmed-article:9243037 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9243037 | lifeskim:mentions | umls-concept:C0015967 | lld:lifeskim |
| pubmed-article:9243037 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:9243037 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
| pubmed-article:9243037 | lifeskim:mentions | umls-concept:C0205653 | lld:lifeskim |
| pubmed-article:9243037 | lifeskim:mentions | umls-concept:C0012621 | lld:lifeskim |
| pubmed-article:9243037 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:9243037 | pubmed:dateCreated | 1997-10-10 | lld:pubmed |
| pubmed-article:9243037 | pubmed:abstractText | During the past decade, a relatively lower-risk patient population of febrile neutropenic children with cancer (over one-half of all these patients) has been identified. These patients can be safely discharged from the hospital before their absolute neutrophil count (ANC) exceeds 500/mm3. To evaluate the practice of early discharge of these patients, 580 consecutive episodes of chemotherapy-induced febrile neutropenia in 253 children and adolescents with cancer between June 1992 and May 1995 were reviewed. Three hundred thirty episodes ended in discharge before the patient's ANC was > 500/mm3. Patients were characterized as being at relatively lower risk if they had sterile blood cultures, were afebrile for > 24 hours, appeared well, and were thought to have evidence of marrow recovery. Of the 330 episodes, only 21 (6%) were associated with admission for recurrent fever during the subsequent 7 days. In retrospect, in only six of these 21 cases of readmission (or 2% of 330 episodes) was there evidence of bone marrow recovery, and none of the blood cultures were positive during the subsequent hospitalization. All patients who met low-risk criteria fared well during their second hospitalization. This early discharge strategy was safe and resulted in substantial cost savings. | lld:pubmed |
| pubmed-article:9243037 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9243037 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9243037 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9243037 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9243037 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9243037 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:9243037 | pubmed:issn | 1058-4838 | lld:pubmed |
| pubmed-article:9243037 | pubmed:author | pubmed-author:BuchananG RGR | lld:pubmed |
| pubmed-article:9243037 | pubmed:author | pubmed-author:AquinoV MVM | lld:pubmed |
| pubmed-article:9243037 | pubmed:author | pubmed-author:TkaczewskiII | lld:pubmed |
| pubmed-article:9243037 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9243037 | pubmed:volume | 25 | lld:pubmed |
| pubmed-article:9243037 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9243037 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9243037 | pubmed:pagination | 74-8 | lld:pubmed |
| pubmed-article:9243037 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:9243037 | pubmed:meshHeading | pubmed-meshheading:9243037-... | lld:pubmed |
| pubmed-article:9243037 | pubmed:meshHeading | pubmed-meshheading:9243037-... | lld:pubmed |
| pubmed-article:9243037 | pubmed:meshHeading | pubmed-meshheading:9243037-... | lld:pubmed |
| pubmed-article:9243037 | pubmed:meshHeading | pubmed-meshheading:9243037-... | lld:pubmed |
| pubmed-article:9243037 | pubmed:meshHeading | pubmed-meshheading:9243037-... | lld:pubmed |
| pubmed-article:9243037 | pubmed:meshHeading | pubmed-meshheading:9243037-... | lld:pubmed |
| pubmed-article:9243037 | pubmed:meshHeading | pubmed-meshheading:9243037-... | lld:pubmed |
| pubmed-article:9243037 | pubmed:meshHeading | pubmed-meshheading:9243037-... | lld:pubmed |
| pubmed-article:9243037 | pubmed:meshHeading | pubmed-meshheading:9243037-... | lld:pubmed |
| pubmed-article:9243037 | pubmed:meshHeading | pubmed-meshheading:9243037-... | lld:pubmed |
| pubmed-article:9243037 | pubmed:meshHeading | pubmed-meshheading:9243037-... | lld:pubmed |
| pubmed-article:9243037 | pubmed:meshHeading | pubmed-meshheading:9243037-... | lld:pubmed |
| pubmed-article:9243037 | pubmed:meshHeading | pubmed-meshheading:9243037-... | lld:pubmed |
| pubmed-article:9243037 | pubmed:meshHeading | pubmed-meshheading:9243037-... | lld:pubmed |
| pubmed-article:9243037 | pubmed:meshHeading | pubmed-meshheading:9243037-... | lld:pubmed |
| pubmed-article:9243037 | pubmed:meshHeading | pubmed-meshheading:9243037-... | lld:pubmed |
| pubmed-article:9243037 | pubmed:meshHeading | pubmed-meshheading:9243037-... | lld:pubmed |
| pubmed-article:9243037 | pubmed:meshHeading | pubmed-meshheading:9243037-... | lld:pubmed |
| pubmed-article:9243037 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9243037 | pubmed:articleTitle | Early discharge of low-risk febrile neutropenic children and adolescents with cancer. | lld:pubmed |
| pubmed-article:9243037 | pubmed:affiliation | Department of Pediatrics, University of Texas Southwestern Medical Center at Dallas 75235-9063, USA. | lld:pubmed |
| pubmed-article:9243037 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9243037 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:9243037 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9243037 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9243037 | lld:pubmed |
